Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
162 employees · est. 2019 · Burlingame, United States
Standigm is the older company (2019 vs 2015); Genesis Molecular AI is the larger of the two.
Side-by-Side Comparison
| Metric | Genesis Molecular AI | Standigm |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2015 older |
| Headquarters | ||
| Headquarters | Burlingame, United States | Seoul, Korea South |
| Employees | ||
| Employees | 162 larger | 25 |
| Industry | ||
| Industry | AI, Biotechnology, Information Technology | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Series D |
| Total Funding | ||
| Total Funding | $280.13M | $371.24M |
| Funding Rounds | ||
| Funding Rounds | 5 | 8 |
| Services | ||
| Services | AI Research and Development, Molecular Design AI Platform, Drug Discovery Solutions, Pharma Partnership Programs | AI SaaS & API Solutions, Novel Target Identification, Hit & Lead Optimization, Pipeline Management, Data-Driven AI Platforms |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, Medical Research Institutions, Drug Development Teams | Pharmaceutical Companies, Biotech Startups, Healthcare Research Institutes, Academic and Research Organizations |
| Taxonomy | ||
| Taxonomy | Molecular AI, Drug Discovery, Generative AI, Predictive Modelling, Biophysics, Pharmaceuticals, Generative Diffusion Model, Lead Optimization, AI-enabled Drug Design, Biotech Collaborations, Deep Neural Networks, Chemical Synthesis Optimization, Undruggable Targets | AI Drug Discovery, Workflow AI, Target Identification, Lead Generation, Drug Repurposing, Molecular Design Workflow, DarkMolFactory, Standigm ASK, Standigm BEST, Standigm Insight, Deep Learning, Automation In Drug Discovery, Novel Target Identification, First-in-Class Lead Compounds |
| Website | ||
| Website | genesistherapeutics.ai | standigm.com |
About Genesis Molecular AI
Genesis Molecular AI, founded in 2019 and headquartered in the United States, is advancing the intersection of AI and Biotechnology to expedite new medicine discovery. The company’s proprietary platform, GEMS (Genesis Exploration of Molecular Space), leverages leading-edge generative and predictive...
About Standigm
Standigm, founded in 2015, is a pioneering workflow AI-driven drug discovery company headquartered in Korea South. The company specializes in utilizing artificial intelligence to streamline and expedite the drug discovery process, targeting industries such as AI, Biotechnology, Health Care, Pharmace...
We will tell you when either one moves
BounceWatch watches Genesis Molecular AI and Standigm for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Genesis Molecular AI and Standigm — by email.
Frequently Asked Questions
Compare Genesis Molecular AI with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Genesis Molecular AI on 24 Aug 2026, and Standigm on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.